Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS

Detalles Bibliográficos
Autores principales: Hodecker, Sibylle C., Stürner, Klarissa H., Becker, Veit, Elias-Hamp, Birte, Holst, Brigitte, Friese, Manuel A., Heesen, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Clinical/Scientific Notes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299629/
https://www.ncbi.nlm.nih.gov/pubmed/28210661
http://dx.doi.org/10.1212/NXI.0000000000000325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299629/
https://www.ncbi.nlm.nih.gov/pubmed/28210661
http://dx.doi.org/10.1212/NXI.0000000000000325

Ejemplares similares